avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Glis2
|
ENSMUSG00000014303.7 | GLIS family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Glis2 | mm10_v2_chr16_+_4594683_4594735 | 0.57 | 2.7e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
1.3 | 3.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.2 | 3.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) |
1.2 | 3.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.8 | 4.8 | GO:0032796 | uropod organization(GO:0032796) |
0.8 | 3.2 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.8 | 6.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 1.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.4 | 6.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.7 | GO:0060032 | notochord regression(GO:0060032) |
0.3 | 1.0 | GO:1902870 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.3 | 0.8 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.3 | 1.1 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 0.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 7.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 2.5 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 1.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 1.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.9 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 3.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.4 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 0.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 1.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.2 | 3.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 2.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 2.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.7 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 2.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 2.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.3 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.3 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.8 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.1 | 0.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.6 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.9 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 1.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 1.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.9 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.0 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 1.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 1.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.5 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.8 | 6.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.7 | 10.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 3.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.3 | 3.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 5.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.8 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 4.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 2.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 1.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 3.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 2.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.9 | 3.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 3.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 6.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 3.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 2.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 2.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 2.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 4.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.6 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.6 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 1.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) Krueppel-associated box domain binding(GO:0035851) |
0.2 | 10.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 3.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 2.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 4.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 1.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.9 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 1.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 2.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.0 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 1.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 1.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 3.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 3.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 3.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 3.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 2.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 3.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 3.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 5.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 3.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 2.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 1.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |